The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours

Oncology Reports

Volumn 25, Issue 1, 2011, Pages 13-22

  Staibano, Stefania ^a   Mascolo, Massimo ^a   Rocco, Alba ^b   Muzio, Lorenzo Lo ^c,e   Ilardi, Gennaro ^a   Siano, Maria ^a   Pannone, Giuseppe ^d   Vecchione, Maria Luisa ^a   Nugnes, Loredana ^a   Califano, Luigi ^a   Zamparese, Rosanna ^f   Bufo, Pantaleo ^d   De Rosa, Gaetano ^a,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Gastroenterology Unit   (Italy)

^c Department of Surgical Sciences   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^f CG Mazzoni   (Italy)

Author keywords

Aggressive behaviour; Chromatin Assembly Factor 1; Salivary gland tumours

Indexed keywords

CHROMATIN ASSEMBLY FACTOR 1; KI 67 ANTIGEN; PROTEIN P60;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; ARTICLE; ASPIRATION CYTOLOGY; BENIGN TUMOR; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOGENESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHILD; CHROMATIN ASSEMBLY FACTOR-1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SALIVARY GLAND NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 78650731401     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001036     Document Type: Article

References (49)

1. Eveson JV, Auclair P, Gnepp DR and El-Naggar AK: Tumors of the salivary glands: introduction. In: World Health Organization Classification of Tumours Pathology and Genetics of Head and Neck Tumours. Barnes L, Everson JW, Reichart P and Sidrandky D (eds). IARC Press, Lyons, pp212-215, 2005.
2. Cheuk W and Chan JKC: Salivary glands tumors. In: Diagnostic Histopathology of Tumors. Fletcher CDM (ed). Livingstone, Churchill, pp239-326, 2007.
3. Cheuk W and Chan JK: Advances in salivary gland pathology. Histopathology 51: 1-20, 2007.
4. Ben-Izhak O, Laster Z, Araidy S and Nagler MR: TUNEL -an efficient prognosis predictor of salivary malignancies. Br J Cancer 96: 1101-1106, 2007.
5. Skálová A, Stárek I, Vanecek T, et al: Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology 42: 348-356, 2003.
6. Luukkaa H, Klemi P and Leivo I: Prognostic significance of Ki-67 and p53 as tumour markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 5: 669-675, 2006.
7. Skalova A, Leivo I, von Boguslawsky K and Saksela E: Cell proliferation correlates with prognosis in acinic cell carcinomas in salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol 173: 13-21, 1994. (Pubitemid 24182256)
8. Skalova A, Lehtonen H, von Boguslawsky K and Leivo I: Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland. Clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25: 929-935, 1994. (Pubitemid 24292411)
9. Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M and Viale G: Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 181: 323-329, 1997.
10. Nordgard S, Franzen G, Boysen M and Halvorsen TB: Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 107: 531-536, 1997.
11. Kiyoshima T, Shima K, Kobayashi I, et al: Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 37: 315-322, 2001.
12. Xin W and Paulino AF: Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification. Ann Diagn Pathol 6: 205-210, 2002.
13. Mello JA and Almouzni G: The ins and outs of nucleosome assembly. Curr Opin Genet Dev 11: 136-141, 2001.
14. Smith S and Stillman B: Purification and characterization of CAF-1, a human cell factor required for chromatin assembly during DNA replication in vitro. Cell 58: 15-25, 1989.
15. Kaufman PD, Kobayashi R, Kessler N and Stillmann B: The p150 and p60 subunits of chromatin assembly factor 1: a molecular link between newly synthesized histones and DNA replication. Cell 81: 1105-1114, 1995.
16. Ridgway P and Almouzni G: CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair. J Cell Sci 113: 2647-2658, 2000.
17. Ye X, Franco AA, Santos H, Nelson DM, Kaufmann PD and Adams PD: Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol Cell 11: 341-351, 2003.
18. Polo SE, Yheocharis SE, Klijaieko J, et al: Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferative cells. Cancer Res 64: 2371-2381, 2004.
19. Staibano S, Mignogna C, Lo Muzio L, et al: Chromatin assembly factor-1 (CAF-1) mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology 50: 911-919, 2007.
20. Staibano S, Mascolo M, Mancini FP, et al: Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. Histopathology 54: 580-589, 2009.
21. Salivary glands. In: World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Barnes L, Everson JW, Reichart P and Sidrandky D (eds). IARC Press, Lyons, pp209-282, 2005.
22. Major salivary glands (parotid, submandibular, and sublingual). In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. Greene FL, Page DL and Fleming ID (eds). 7th edition. Springer, New York, NY, pp103-109, 2010.
23. Jalava P, Kuopio T and Juntti-Patinen L: Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on KI67 immunoreactivity and standardized mitotic index. Histopathology 48: 674-682, 2006.
24. Detre S, Saclani Jotti G and Dowsett M: A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48: 876-878, 1995.
25. Weintraub J, Redard M, Wenger D and Vassilakos P: The application of immunocytochemical technique to routinely fixed and stained cytologic specimens. An aid in the differential diagnosis of undifferentiated malignant neoplasms. Pathol Res Pract 186: 658-665, 1990.
26. Landis JR and Koch GG: The measurement of observer agreement for categorical data. Biometrics 33: 159-174, 1997.
27. Zweigh MH and Campbell G: Receiver operating characteristic (ROC) plats: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577, 1993.
28. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ and Rinaldo A: Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcome. Acta Otolaryngol 122: 758-764, 2002.
29. El-Naggar AK, Dinh M, Tucker Sl, Gillenwater A, Luna MA and Batsakis JG: Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry. Hum Pathol 28: 881-886, 1997.
30. El-Naggar AK, Hurr K, Kagan J and Batsakis JG: Genotypic alterations in benign and malignant salivary gland tumour: histogenetic and clinical implications. Am J Surg Pathol 21: 691-697, 1997.
31. Edwards PC, Bhuiya T and Kelsch RD: C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 586-593, 2003.
32. Gatta G, Ciccolallo L, Kunkler I, et al: Survival from rare case in adults: a population-based study. Lancet Oncol 7: 132-140, 2006.
33. Uro-Coste E: Tumeurs des glandes salivaires. E'tat des lieux en 2009-2009 update in salivary gland tumoral pathology. Ann Pathol 29: 274-285, 2009.
34. Williams MD, Chakravarti N, Kies MS, et al: Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res 12: 7353-7358, 2006.
35. Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T and Konishi N: Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41: 161-169, 2005.
36. Maruya S, Kim HW, Weber RS, et al: Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. J Mol Diagn 6: 180-190, 2004.
37. Polo SE and Almouzni G: Chromatin assembly: a basic recipe with various flavours. Curr Opin Genet Dev 16: 104-111, 2006.
38. Norberg-Spaak L, Dardick I and Ledin T: Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 22: 489-497, 2000.
39. Michael M, Skalova A, Simpson RH, Laivo I, Ryska A and Starek I: Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Hum Pathol 28: 595-600, 1997.
40. Perez-Ordonez B, Linkov I and Huvos AG: Polymorphous lowgrade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation. Histopathology 32: 521-529, 1998.
41. Lazzaro B and Cleveland D: P53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 613-617, 2000.
42. Zhao M, Zhao QX, Saitoh M, et al: Proliferating patterns of salivary gland adenocarcinomas with the use of PCNA labeling. Anticancer Res 16: 2693-2698, 1996.
43. Auclair PL and Ellis GL: Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol 9: 652-657, 1996.
44. Marioni G, Marino F, Stramare R, Marchese-Ragona R and Staffieri A: Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle. Head Neck 25: 1071-1076, 2003.
45. Spyratos F, Ferrero-Poüs M, Trassard M, et al: Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 94: 2151-2159, 2002
46. Eveson JV, Kasafuka K, Stenman G and Nagao T: Pleomorphic adenoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Barnes L, Everson JW, Reichart P and Sidrandky D (eds). IARC Press, Lyons, pp254-258, 2005.
47. LiVolsi VA and Perzin KH: Malignant mixed tumours arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 39: 2209-2230, 1977.
48. Altemani A, Martins MT, Freitas L, Soares F, Araujo NS and Araujo VC: Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 46: 635-641, 2005.
49. Milano A, Longo F, Basile M, Iaffaioli RV and Caponigro F: Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 43: 729-34, 2007